BindingDB logo
myBDB logout

BDBM237828 US9394282, 6-15

SMILES: Cc1c(CN2CC[C@@H](C#N)[C@@H](C2)n2cc(C(N)=O)c(Nc3ccc(F)cc3)n2)cnn1C

InChI Key: InChIKey=UNFWUMOFMBRIDS-MGPUTAFESA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 237828   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM237828
PNG
(US9394282, 6-15)
Show SMILES Cc1c(CN2CC[C@@H](C#N)[C@@H](C2)n2cc(C(N)=O)c(Nc3ccc(F)cc3)n2)cnn1C |r|
Show InChI InChI=1S/C22H25FN8O/c1-14-16(10-26-29(14)2)11-30-8-7-15(9-24)20(13-30)31-12-19(21(25)32)22(28-31)27-18-5-3-17(23)4-6-18/h3-6,10,12,15,20H,7-8,11,13H2,1-2H3,(H2,25,32)(H,27,28)/t15-,20+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 20n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ...


US Patent US9394282 (2016)


BindingDB Entry DOI: 10.7270/Q2J10233
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM237828
PNG
(US9394282, 6-15)
Show SMILES Cc1c(CN2CC[C@@H](C#N)[C@@H](C2)n2cc(C(N)=O)c(Nc3ccc(F)cc3)n2)cnn1C |r|
Show InChI InChI=1S/C22H25FN8O/c1-14-16(10-26-29(14)2)11-30-8-7-15(9-24)20(13-30)31-12-19(21(25)32)22(28-31)27-18-5-3-17(23)4-6-18/h3-6,10,12,15,20H,7-8,11,13H2,1-2H3,(H2,25,32)(H,27,28)/t15-,20+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1n/an/an/an/an/an/a



Merck Sharp & Dohme Corp.

US Patent


Assay Description
The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain ...


US Patent US9394282 (2016)


BindingDB Entry DOI: 10.7270/Q2J10233
More data for this
Ligand-Target Pair